Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Indigenous Microbiota Protects against Inflammation-Induced Osteonecrosis
D. W. Williams
,
H. E. Vuong
, S. Kim
, A. Lenon
, K. Ho
, E. Y. Hsiao
, E. C. Sung
, R. H. Kim
Neonatology (Pediatrics)
Basic Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
23
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Indigenous Microbiota Protects against Inflammation-Induced Osteonecrosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Inflammation
100%
Osteonecrosis
100%
Indigenous Microbiota
100%
Antibiotics
75%
Ligature-induced Periodontitis
75%
Medication-related Osteonecrosis of the Jaw (MRONJ)
75%
Osteoclast
50%
Empty Lacuna
50%
Necrotic Bone
50%
Tooth Extraction
25%
MTOR Inhibitor
25%
Oral Lesions
25%
Zoledronic Acid
25%
Advanced Stage
25%
Antiangiogenic Agents
25%
Pathogenic Bacteria
25%
Bone Formation
25%
Healthy Teeth
25%
High-dose Therapy
25%
No Significant Difference
25%
Acid Infusion
25%
Bone Resorption
25%
Jaw Development
25%
Jaw Lesions
25%
Local Inhibition
25%
Bacterial Infiltration
25%
Indigenous Microbes
25%
Nitrogen-containing Bisphosphonates
25%
Oral Flora
25%
RANKL Inhibitors
25%
Zoledronic
25%
Oral Dysbiosis
25%
Immunology and Microbiology
Microflora
100%
Jaw
100%
Teeth
100%
Periodontitis
100%
Osteoclast
66%
Surface Area
66%
Osteolysis
33%
Drug Megadose
33%
Mouth Flora
33%
RANKL
33%
Ossification
33%
Angiogenesis Inhibitor
33%
Dysbiosis
33%
Medicine and Dentistry
Bone Necrosis
100%
Periodontitis
75%
Medication-Related Osteonecrosis Of The Jaw
75%
Osteoclast
50%
Oral
50%
Mouth Lesion
25%
Drug Megadose
25%
Zoledronic Acid
25%
Ossification
25%
Infusion
25%
Tooth Extraction
25%
Bisphosphonate
25%
Angiogenesis Inhibitor
25%
Osteoclast Differentiation Factor
25%
Mammalian Target of Rapamycin Inhibitor
25%
Dysbiosis
25%
Osteolysis
25%